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Abstract
Purpose: Pericardial adipose tissue had been shown to exert local effects on adjacent cardiac
structures. Data regarding the mechanistic link between such measures and left atrial (LA)
structural/functional remodeling, a clinical hallmark of early stage heart failure (HF) and atrial
fibrillation (AF) incidence, in asymptomatic population remain largely unexplored.
Methods: This retrospective analysis includes 356 subjects free from significant valvular
disorders, atrial fibrillation, or clinical HF. Regional adipose tissue including pericardial and
periaortic fat volumes, interatrial septal (IAS), and left atrioventricular groove (AVG) fat
thickness were all measured by multidetector computed tomography (MDCT) (Aquarius
3D Workstation, TeraRecon, San Mateo, CA, USA). We measured LA volumes, booster
performance, reservoir capacity as well as conduit function, and analyzed their association
with adiposity measures.
Results: All four adiposity measures were positively associated with greater LA volumes
(all P < 0.05), while IAS and AVG fat were also related to larger LA kinetic energy and
worse reservoir capacity (both P < 0.01). In multivariate models, IAS fat thickness remained
independently associated with larger LA volumes, increased LA kinetic energy and ejection
force (β-coef: 0.17 & 0.15, both P < 0.05), and impaired LA reservoir and conduit function
(β-coef: −0.20 & −0.12, both P < 0.05) after adjusting for clinical variables.
Conclusion: Accumulated visceral adiposity, especially interatrial fat depots, was associated
with certain LA structural/functional remodeling characterized by impaired LA reservoir
and conduit function though augmented kinetic energy and ejection performance. Our
data suggested that interatrial fat burden may be associated with certain detrimental LA
functions with compensatory LA adaptation in an asymptomatic population.
This work is licensed under a Creative Commons
Attribution-NonCommercial 4.0 International
License.

© 2016 The authors
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Introduction
Over the past decade, assessment of left atrial (LA) function
has been shown to be crucial in maintaining adequate
cardiac mechanistic performance and pump function
in subjects with preserved left ventricular (LV) systolic
function with sinus rhythm (1). Throughout the cardiac
cycle, LA serves multiple roles. First as a reservoir receiving
pulmonary venous return during ventricular systole, then
as an open conduit directing the influx of blood flow into
LV during early diastole, and finally as an active booster
pump during late diastole (2). It is well-established that
the reservoir, conduit, and booster functions of LA are key
factors to ventricular filling performance, and may serve as
clinical surrogate of LA dysfunction at an earlier stage (2, 3).
Several clinical risk factors, including obesity, metabolic derangements, and LV hypertrophy secondary to
chronic pressure overload, had all been shown to affect
LA structure and function negatively (4). Numerous studies had demonstrated that the pathogenesis between
central obesity and cardiovascular diseases (5, 6) may
be partially mediated by the pericardial adipose tissue,
a hypothetical source of inflammatory and atherogenic
cytokines with active biological effects (7, 8). As a result of
its anatomic proximity and shared blood supply with the
myocardium, pericardial fat had been reported to influence various aspects of cardiac function, including LA
remodeling (9) and the development of atrial fibrillation
(AF) (10, 11). On the other hand, far less effort had been
invested in the possible effects that atrial septal fat accumulation (also known as lipomatous septal hypertrophy)
may impose on specific LA mechanics.
On the basis of this hypothesis, we sought to examine the link among different sites of visceral adiposity
with LA structural remodeling and its related mechanistic
performances in an asymptomatic population. We also
speculated that visceral fat accumulation surrounding
interatrial location is associated with some components
of LA functional impairment, and will further investigate
these issues.

Subjects and methods
Subjects
We consecutively studied subjects who received
cardiovascular health examinations from 2010 to 2013
at a tertiary medical center in Taipei, Taiwan. The clinical
setting was for clinical cardiovascular risk stratification
at cardiovascular outpatient service, which was similar
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to our previously published data (12, 13). All study
subjects underwent detailed review of medical histories,
along with physical examination performed in all study
subjects. Clinical symptoms including angina, chest
discomfort, or heart failure (e.g. exercise intolerance) were
all obtained, with subspecialty transferred if appropriate.
Transthoracic echocardiography, electrocardiography
(ECG), and cardiac computed tomography (CT) for
coronary calcium scoring were performed in all subjects.
Patients with acute decompensated heart 
failure
(HF), unstable angina, atrial flutter/fibrillation (either
persistent or paroxysmal), severe valvular disease (either
stenosis or regurgitation), or end-stage renal disease
were excluded. A total of 356 subjects after exclusion
during study period were finally enrolled. The presence
of CAD was defined as a history of previous myocardial
infarction, previous angioplasty, or more than 50 %
luminal narrowing diagnosed by coronary angiography.
Hypertension was defined as systolic blood pressure above
140 mmHg, diastolic blood pressure above 90 mmHg
or previously diagnosed hypertension under regular
medication control. Diabetes was defined as a fasting
glucose level above 126 mg/dL or previously diagnosed
diabetes with 
medication use. Hyperlipidemia was
defined as a history and/or use of lipid-lowering drugs
such as statins or fibrates on a daily basis. Standardized
sphygmomanometer
cuff-defined
resting
blood
pressures were measured at rest by medical staff blinded
to the other test results. All baseline characteristics and
information regarding anthropometric measures were
collected, which included body size in terms of body
mass index (BMI) and waist circumference.
This study has been approved by Mackay Memorial
Hospital Institutional Review Board with adherence to
research ethics (IRB number: 14MMHIS161).
Echocardiography and LA mechanics measures
Each subject underwent two-dimensional (2D) and color
Doppler transthoracic echocardiography using a commercially available ultrasound system (Vivid 7, GE Medical
System, Vingmed, Norway) equipped with 2–4 MHz transducer at the left decubitus position. All recorded images
were measured and analyzed with clinical information
blinded using a computerized off-line software (TomTec Image Arena, Munich, Germany). All measurements
were averaged from three consecutive cardiac cycles. LV
wall thickness and mass were determined from M-mode
method. LV volumes and ejection fraction were obtained
via the modified biplane Simpson method from the apical
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four- and two-chamber views according to American
Society of Echocardiography recommendations (14).

Diastolic functional parameters including early mitral

inflow velocity (E), late mitral inflow velocity (A), deceleration time (DT), iso-volumic relaxation time (IVRT),
and tissue Doppler imaging (TDI)-derived mitral annular
early-diastolic velocity (eʹ) were all obtained. The average
eʹ velocity between LV basal septal and lateral segments
was used for our statistical analysis. Average E/eʹ ratio was
used to predict LV filling pressures (15).
For volumetric assessment of LA reservoir, conduit,
and booster functions, maximum LA volume (LAV max,
at end-systole, just before mitral valve opening), pre-A
LA volume (LAV pre-A, immediately before atrial contraction, marked by the electrocardiographic P-wave),
and minimum LA volume (LAV min, at end-diastole,
when the mitral valve closes) were measured by biplane
method and indexed to body-surface area (14, 16) (Fig. 1).
LA reservoir function was estimated by expansion index,
computed as [(LAV max – LAV min)/LAV min] × 100%.
LA booster function was estimated by active emptying fraction, computed as [(LAV pre-A – LAV min)/LAV
pre-A] × 100%. LA conduit function was estimated by
passive emptying fraction, computed as [(LAV max – LAV
pre-A)/LAV max] × 100% (2). Advanced markers of atrial
systolic function such as LA ejection force and kinetic
energy were calculated according to the modified
Manning method. LA kinetic energy (kdynes·cm/m2)

was defined as 0.5 × ρ × LA active emptying volume × A2,

Figure 1
LA volumes measured by biplane area-length method. Volume curve was
obtained by continuous speckle tracking. Minimum volume (LAV min) is
measured at the closure of the mitral valve in end-diastole. Maximum
volume (LAV max) is measured just before the opening of the mitral valve
in end-systole. Pre-A volume (LAV pre-A) is measured at the onset of the
P-wave on electrocardiogram.
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where ρ was blood density (1.06 g/cm3) and A was
late-diastolic mitral inflow velocity (cm/s) (17). LA
ejection force (kdynes/m2) was defined as (0.5 × ρ × LA

active 
emptying volume × A2)/late-diastolic transmitral
flow velocity time integral (VTIA, cm) (17). Finally, a subset
sample of 50 cases was selected for comparing continuous
speckle tracking analysis and manually traced method for
echo-defined LA volume data in our lab, which showed high
correlation (r = 0.96, P < 0.05). To further validate the
accuracy of our echo-based LA volumes, we randomly
selected 59 cases who received contrast-enhanced computed tomography (CECT) using multidetector computed
tomography (MDCT) coronary artery imaging 
protocol
during the study conduction time. LA volumes were
then quantified and compared with echo-based measures
which had been approved by research ethics committee.
Quantification of regional pericardial and periaortic fat
All participants had undergone MDCT originally for
coronary calcium score measurement, and we reconstructed the images for visceral fat assessment. MDCT
was performed by using a 16-slice scanner (Sensation 16,
Siemens Medical Solutions, Forchheim, Germany) with
16 mm × 0.75 mm collimation, rotation time 420 ms
and tube voltage of 120 kV. In one breath-hold, images
were acquired from above the level of tracheal bifurcation to below the base of heart using prospectively ECG
triggering with the centre of the acquisition at 70% of
the R-R interval. From the raw data, the images were
reconstructed with standard kernel in 3 mm thick axial,
non-overlapping slices and 25 cm field of view.
Visceral adipose tissue measurements were c arried out
offline (Aquarius iNtuition Cloud, TeraRecon, SanMateo,
CA, USA) on a single workstation using methods described
previously (18). Total pericardial adipose tissue volumes
were quantified using a semi-automatic segmentation
technique, in which the region of interest was defined by
manually tracing the pericardial borders. Fat tissue was
defined as pixels within a window of −195 to −45 HU, and
pericardial fat was then selected as adipose tissue within
the pericardial sac (Fig. 2A). Thoracic periaortic adipose
tissue was defined as all adipose tissue surrounding the
thoracic aorta extending 67.5 mm caudally from the level
of the bifurcation of the pulmonary arteries (Fig. 2B).
For regional fat thickness measurements, we performed
multiplanar reconstructions to obtain the standardized
horizontal long-axis plane from axial and longitudinal
two-chamber views for subsequent measurement of the
interatrial septum (IAS) and left atrioventricular groove
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Figure 2
(A) 3D-reconstruction of total pericardial fat volume from each axial image (left panel). Pericardial fat (orange shadow) was selected as all adipose tissue
within the pericardial sac and subtracted from the adjacent cardiac structures (right panel). (B) 3D-reconstruction of thoracic periaortic fat from each
axial image (left panel). Thoracic periaortic fat (orange shadow) was defined as all adipose tissue surrounding the thoracic aorta extending 67.5 mm
caudally from the level of the bifurcation of the pulmonary arteries (right panel). (C) Multiplanar reconstructions (red line for each plane) for regional
fat thickness measurements over the interatrial septum (IAS) and left atrioventricular (AV) groove.

(AVG) based on methods validated by a previous study
(19) (Fig. 2C). For reproducibility assessment, intraobserver and inter-observer coefficients of variation were
determined by repeated measurement on 50 randomized
cases by two experienced readers blinded to the subjects’
clinical data. The intra-observer and inter-observer
coefficients of variation for pericardial fat and interatrial
fat were 4.27%, 4.87% and 6.58%, 6.81%, respectively.

Statistical analysis
Continuous data were shown as mean with standard
deviation. Categorical information was expressed as
the frequency and proportion of prevalence, and then
compared using a χ2-test or Fisher’s exact test if appropriate.
Baseline continuous data were compared by a Wilcoxon
nonparametric test for significant trend across regional
adipose tissue (IAS) strata based on tertiles. The trend

between LA/LV structural/functional parameters and
increasing IAS fat volume was examined across IAS strata,
with uni- and multi-variable regression models used to
determine the associations between various regional
adipose tissue burden and LA mechanical/functional

indices (including volumes, booster performance,
reservoir capacity as well as conduit function).
All data were analyzed using a commercial software
STATA 8.2 package (Stata Corp, College Station, TX, USA).
The significance of p level (α-value) for all analysis was
two-sided, with a value less than 0.05 considered to be
statistically significant.

Results
Basic information, biomarkers and adiposity measures
The associations of IAS fat with baseline demographics,
biochemical, or inflammatory markers and other
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Table 1 Relationship of baseline demographics, biochemical and inflammatory markers, medical histories, and other adiposity
measures with interatrial fat.
Interatrial fat thickness (mm)

Baseline demographics
Age (years)
Male (%)
SBP (mmHg)
DBP (mmHg)
BMI (kg/m2)
WC (cm)
Body fat (%)
Biochemical data
Fasting glucose (mg/dL)
HbA1c (%)
Cholesterol (mg/dL)
TG (mg/dL)
LDL (mg/dL)
HDL (mg/dL)
eGFR (mL/min/m2)
hs-CRP (mg/dL)
Insulin (μIU/mL)
HOMA-IR (IU/mL)
CCS
Medical histories
Hyperlipidemia (%)
Hypertension (%)
Diabetes (%)
CAD history (%)
Adiposity measures
Pericardial fat (mL)
Pericardial fat index (mL/m2)
Periaortic fat (mL)
Periaortic fat index (mL/m2)
Left AVG fat (mm)

1st tertile group

2nd tertile group

3rd tertile group

2.00–2.48

4.83–6.36

6.37–10.8

(n = 119)

(n = 119)

(n = 118)

50.25 ± 7.90
71 (60.17%)
119.16 ± 16.76
75.90 ± 10.42
23.40 ± 2.77
80.72 ± 8.43
25.69 ± 6.70

50.77 ± 9.05
81 (69.23%)
121.34 ± 16.37
74.91 ± 10.79
24.49 ± 2.64
83.42 ± 8.19
25.28 ± 6.17

54.09 ± 9.24
93 (78.15%)
125.15 ± 16.63
77.92 ± 10.47
25.86 ± 3.00
89.15 ± 8.06
27.86 ± 7.15

0.003
0.007
0.048
0.113
<0.001
<0.001
0.051

95.26 ± 11.15
5.84 ± 0.54
201.04 ± 36.34
122.47 ± 56.54
133.48 ± 31.30
51.97 ± 12.89
85.76 ± 13.70
0.18 ± 0.16
5.35 ± 2.87
1.24 ± 0.83
145.9 ± 38.51

99.81 ± 17.57
5.93 ± 0.59
198.30 ± 35.07
139.09 ± 88.32
128.48 ± 33.20
51.96 ± 14.35
86.88 ± 16.07
0.17 ± 0.16
5.88 ± 3.17
1.44 ± 0.92
105.4 ± 21.49

104.90 ± 26.21
6.15 ± 1.05
198.26 ± 36.87
160.07 ± 92.94
129.93 ± 30.09
45.69 ± 10.61
83.22 ± 19.95
0.33 ± 0.34
7.17 ± 3.87
1.86 ± 1.33
123.52 ± 52.56

<0.001
0.079
0.786
0.004
0.444
0.001
0.173
<0.001
0.004
0.001
0.117

0.09 ± 0.29
0.22 ± 0.42
0.08 ± 0.27
0.01 ± 0.11

0.14 ± 0.35
0.27 ± 0.45
0.14 ± 0.35
0.05 ± 0.22

0.14 ± 0.35
0.34 ± 0.47
0.22 ± 0.42
0.04 ± 0.19

0.534
0.138
0.008
0.337

79.25 ± 21.96
28.46 ± 5.91
7.64 ± 3.09
3.19 ± 1.53
3.99 ± 1.02

83.06 ± 27.96
42.04 ± 5.73
8.49 ± 3.91
4.02 ± 1.51
5.37 ± 0.67

80.72 ± 29.13
57.69 ± 9.7
8.19 ± 4.14
5.63 ± 2.07
7.42 ± 1.77

P (trend)

0.539
<0.001
0.208
<0.001
<0.001

SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; TG, triglyceride; LDL, low-density lipoprotein;
HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; Hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostatic model
assessment-estimated insulin resistance; CCS, coronary calcium score; CAD, coronary artery disease; AVG, atrioventricular groove.

adiposity measures were summarized in Table 1. Among
all 356 participants, 245 (68.8%) were men, with an
average age of 51.8 ± 8.8 years. With increasing IAS
fat measure, there were stepwise increases in BMI and
waist circumference (trend P < 0.001). Furthermore,
increasing fat were significantly associated with
graded increase in fasting glucose, triglyceride,
hs-CRP, insulin and insulin resistance (HOMA-IR),
as well as decreased HDL (all trend P < 0.005). The
mean total pericardial fat volume and volume index
were 80.39 ± 26.05 mL, 42.97 ± 13.68 mL/m2, which
were within the normal limit (125 mL or 68 mL/m2)
as suggested by a previous literature (20). Mean IAS
thickness was 5.7 ± 1.71 mm, which was comparable to

the control group data of a previous study (20). Both
pericardial and periaortic fat volumes indexed to bodysurface area had significant increase along with increased
IAS thickness (all P < 0.001). For those subjects without
any known hypertension, diabetes, h
 yperlipidemia or
coronary artery disease, the mean IAS thickness was
5.48 ± 1.7 mm (n = 219). A search of our hospital database
found that 329 (92.4% available) of the participants
were followed at least once in outpatient clinics. The
median follow-up period was 3.4 years. Four patients had
documented atrial fibrillation (AF); two were hospitalized
for heart failure. Five of those six patients were clustered
in the third IAS tertile group; the remaining one came
from the second tertile group (P = 0.025).
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Table 2 Relationship of LV structural/functional parameters with interatrial fat.
Interatrial fat thickness (mm)

IVS (mm)
PWT (mm)
LVEDV (mL)
LVESV (mL)
LVM (gm)
LVMI (gm/m2)
LVEF (%)
E (cm/s)
A (cm/s)
DT (ms)
IVRT (ms)
eʹ (cm/s)
E/eʹ

1st tertile group

2nd tertile group

3rd tertile group

2.00–2.48

4.83–6.36

6.37–10.8

(n = 119)

(n = 119)

(n = 118)

P (trend)

9.33 ± 1.22
9.03 ± 1.20
96.58 ± 14.87
30.93 ± 7.35
141.90 ± 33.70
77.83 ± 15.89
68.95 ± 2.76
61.51 ± 14.91
60.56 ± 12.28
204.36 ± 45.60
91.44 ± 15.92
10.2 ± 2.66
7.17 ± 2.21

9.60 ± 1.15
9.50 ± 1.22
102.68 ± 15.22
32.89 ± 6.94
156.82 ± 34.22
83.23 ± 14.88
68.56 ± 3.74
61.57 ± 13.48
62.59 ± 12.69
206.94 ± 51.67
93.34 ± 14.32
8.76 ± 3.02
7.9 ± 4.03

10.14 ± 1.15
9.99 ± 1.10
109.32 ± 16.68
34.87 ± 7.85
175.31 ± 39.15
89.21 ± 16.60
68.29 ± 3.46
60.51 ± 16.76
66.18 ± 15.82
211.69 ± 48.49
94.89 ± 17.36
7.8 ± 2.04
8.49 ± 3.19

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.463
0.637
0.018
0.383
0.121
0.014
0.001

IVS, interventricular septum; PWT, posterior wall thickness; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume;
LVM, left ventricular mass; LVMI, left ventricular mass index; LVEF, left ventricular ejection fraction; E, early mitral inflow velocity; A, late mitral inflow
velocity; DT, deceleration time; IVRT, isovolumetric relaxation time; eʹ, early-diastolic tissue velocity.

Echocardiographic parameters and multivariate analysis
The relationship between IAS fat thickness and various
LV structural and functional parameters is presented in
Table 2. Mean LAV max index, LAV pre-A index and LAV
min index were 18.34 ± 6.04 mL/m2, 10.79 ± 3.75 mL/m2,
7.5 ± 3.02 mL/m2, respectively. We observed a high correlation between echo and CT-based LA maximum volume
among 59 random cases in our lab (Echo: 40.6 ± 12.8 ml
vs CT: 48.6 ±11.5 ml, r = 0.94, P < 0.001), with a mean
difference of 7.91 ± 4.25 mL (95% CI: −9.02 to −6.81).
Increasing IAS tertiles were associated with graded
increases in LV wall thickness, chamber size as well as
total LV mass and LV mass index (all trend P < 0.001),

whereas global LV systolic function remained relatively
unaffected. There were no remarkable differences in
mitral inflow Doppler-derived diastolic functional parameters across IAS tertiles, except for a trend towards higher
A velocity with greater IAS (trend P: 0.018). As for TDIderived parameters, there were significant reductions in
average e’ velocity (trend P: 0.014) and increases in E/e’
ratio (trend P: 0.001).
We showed that greater IAS fat was strongly related
to all three volume indices (1st vs 3rd tertiles: 16.85 vs
19.87 mL/m2 for LAV max index, 9.73 vs 12.03 mL/m2
for LAV pre-A index, 6.68 vs 8.61 mL/m2 for LAV min
index, all P < 0.05) (Table 3). With each increasing IAS

Table 3 Relationship of LA structural/functional parameters with interatrial fat.
Interatrial fat thickness (mm)

LAV max index (mL/m2)
LAV pre-A index (mL/m2)
LAV min index (mL/m2)
LA reservoir function/expansion index (%)
LA booster function/active emptying fraction (%)
LA conduit function/passive emptying fraction (%)
LA kinetic energy (kdynes·cm/m2)
LA ejection force (kdynes/m2)

1st tertile group

2nd tertile group

3rd tertile group

2.00–2.48

4.83–6.36

6.37–10.8

(n = 119)

(n = 119)

16.85 ± 5.53
9.73 ± 3.20
6.68 ± 2.55
159.44 ± 46.64
31.94 ± 7.37
41.84 ± 5.77
5.84 ± 2.56
1.12 ± 0.41

18.37 ± 6.03
10.65 ± 3.55
7.27 ± 2.65
157.94 ± 45.65
31.92 ± 6.71
41.59 ± 6.03
7.13 ± 3.55¥
1. 26 ± 0.46¥

(n = 118)

19.87 ± 6.23¥
12.03 ± 4.17¥※
8.61 ± 3.51¥※
142.4 ± 40.8¥※
29.72 ± 6.52¥※
39.97 ± 5.58¥
7.75 ± 3.84¥
1.29 ± 0.43¥

P (trend)

0.001
<0.001
<0.001
0.004
0.022
0.009
<0.001
0.001

LAV max, LA maximum volume; LAV pre-A, LA pre-A volume; LAV min, LA minimum volume.
¥P < 0.05 versus 1st tertile group by ANOVA.
※P < 0.05 versus 2nd tertile group by ANOVA.
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Figure 3
Linear regression plots of (A) left atrial reservoir function, (B) booster function, (C) conduit function, (D) kinetic energy (E) and ejection force in relation to IAS
thickness. The fitted lines point to a gradual decline in all three functional indices and increases in both LA kinetic energy and ejection force (all P < 0.001).

tertile, there was a significant decrease in all three functional parameters (1st vs 3rd tertiles: 159.44 vs 142.4%
for reservoir function/expansion index, 31.94 vs 29.72%
for booster function/active emptying fraction, 41.84 vs

39.97% for conduit function/passive emptying faction,
all P < 0.05). However, both LA kinetic energy and
ejection force had graded increases (1st vs 3rd tertiles:
5.84 vs 7.75 kdynes·cm/m2 for LA kinetic energy,

Table 4 Univariate and multivariate models regarding the differential association between LA structural/functional parameters
and regional fat measures (standardized β-coefficients shown in table).

Model 1
Pericardial fat
Periaortic fat
Left AVG fat
IAS fat
Model 2
Pericardial fat
Periaortic fat
Left AVG fat
IAS fat
Model 3
Pericardial fat
Periaortic fat
Left AVG fat
IAS fat

LAV
max
index

LAV
min
index

LAV
pre-A
index

LA
reservoir
function

0.11*
0.12*
0.15**
0.22***

0.14**
0.13*
0.19***
0.32***

0.14*
0.13*
0.18**
0.30***

–0.07
–0.06
–0.15**
–0.19***

0.09
0.11*
0.14***
0.21

0.12*
0.11*
0.16**
0.29***

0.12*
0.11*
0.15**
0.29***

–0.05
–0.03
–0.11*
–0.16**

0.05
0.09
0.09
0.19**

0.09
0.07
0.10
0.30***

0.09
0.08
0.11
0.29***

–0.05
0.01
–0.11
–0.20*

LA
booster
function

LA
conduit
function

LA
kinetic
energy

LA
ejection
force

0.07
0.08
0.10
–0.13*

0.13*
0.18***
0.10
–0.15**

0.07
0.06
0.17**
0.18***

0.05
0.05
0.10
0.14***

0.12*
0.17**
0.09
–0.13*

0.06
0.04
0.14*
0.17**

0.05
0.04
0.08
0.13*

0.07
0.15*
0.08
–0.12*

0.05
0.02
0.17*
0.17*

0.04
0.02
0.10
0.15*

0.08
0.08
0.11
0.14**
0.04
0.07
0.08
–0.13

LAV max, LA maximum volume; LAV pre-A, LA pre-A volume; LAV min, LA minimum volume; AVG, atrioventricular groove; IAS, interatrial septum.
Model 1: Univariate.
Model 2: Multivariate: adjusted for age, gender.
Model 3: Multivariate: adjusted for age, gender, eGFR, LV mass, history of hypertension, diabetes, hyperlipidemia or CAD.
*P < 0.05; **P < 0.01; ***P < 0.001.
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1.12 vs 1.29 kdynes/m2 for LA ejection force, both
P < 0.05). Figure 3 shows the linear regression analysis
and scatter plots for the afore-mentioned parameters
in relation to IAS fat thickness. The fitted lines point
to a gradual decline in all three functional indices and
increases in both LA kinetic energy and ejection force
(all P < 0.001).
Table 4 presents both univariate and multivariate
models regarding the differential association between
LA structural/functional parameters and regional fat
measures. In univariate analysis, both IAS and left AVG
fat thickness were significantly related to increased LA
volumes, impaired LA reservoir function (β-coef: −0.15,
P < 0.01 for AVG fat; β-coef: −0.19, P < 0.001 for IAS fat),
and increased kinetic energy (β-coef: 0.17, P < 0.01 for
AVG fat; β-coef: 0.18, P < 0.001 for IAS fat). In addition,
thicker IAS fat was also associated with decreased LA
booster function (β-coef: −0.13, P < 0.05), conduit function (β-coef: −0.15, P < 0.01), and increased ejection force
(β-coef: 0.14, P < 0.001). In the multivariate analysis,
IAS fat thickness remained significantly associated with
increased LA volumes (β-coef: 0.19, 0.3, 0.29, respectively,
all P < 0.01), increased LA kinetic energy and ejection force
(β-coef: 0.17 & 0.15, respectively, both P < 0.05), impaired
LA reservoir and conduit function (β-coef: −0.2 & −0.12,
respectively, both P < 0.05) after adjusting for age, gender,
eGFR, LV mass, and history of hypertension, diabetes,
hyperlipidemia or CAD.

Discussion
In this study, we observed that regional adiposity in terms
of interatrial fat was partially associated with 
several
LV geometric alterations and diastolic dysfunction.
Furthermore, greater IAS was associated with LA structural
and functional adaptations including LA enlargement,
attenuated reservoir, conduit and booster performance,
yet globally enhanced kinetic energy and ejection force.
After control of multiple variables, these associations
remained mostly significant except for booster function.

Potential mechanisms for the association of interatrial
fat and atrial function
Lipomatous septal hypertrophy is a well-documented
clinical condition associated with sick sinus syndrome
(21) and atrial arrhythmias (22, 23, 24). Previous studies
based on both necropsy (25) and image data (19, 26) had
confirmed that these fatty infiltrates in the interatrial
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septum are proportionately correlated with total pericardial fat volume and one-dimensional fat thickness over
grooved segments. In a previous study by Shin et al. [19],
after dividing 160 patients into persistent AF, paroxysmal AF and control groups, the authors demonstrated
that increased interatrial fat thickness was associated
with AF severity. However, to the best of our knowledge,
no investigation had yet been aimed specifically at the
mechanistic link between interatrial fat and LA structural
remodeling and functional alterations.
It has been previously reported that pericardial fat was
independently associated with metabolic derangements,
fatty liver disease, insulin resistance and systemic inflammation, by utilizing CT measures (13, 27). Histological
studies of lipomatous septal hypertrophy have shown an
abundance of inflammatory cells and fibrosis permeating
throughout the fatty infiltrates (25). It has also been suggested that certain cytokines and inflammation p
 rocess
from accumulated adiposity may have direct adverse
effects on LA mechanics or mediated arrhythmogenesis
(19, 26, 28), leading to consequent structural r emodeling,
conduction disturbances and AF incidence (29). This study
compared the associations among LA regional adiposity,
pericardial, periaortic fat, and several LA structural/
functional measures respectively. Since only interatrial
fat had significant correlations with LA functions after
multivariate adjustment, this may imply that interatrial fat
should be viewed as a separate entity from pericardial fat.
In contrast, AV groove fat may be regarded an extension of
pericardial fat by sharing similar characteristics. While the
enveloping pericardial fat may affect global cardiac function by both mechanical compression and cytokine secretion, the different anatomic nature of interatrial septal fat
suggests a more biochemically oriented pathway.
Previous studies on patients with mild-to-moderate heart
failure symptoms have shown that higher LA contractile or
ejection force and greater kinetic energy may exist in these
patients compared with healthy people (17, 30), possibly as
compensation for maintaining resting cardiac output (31,
32). Our study showed that greater fat depots surrounding
LA, especially interatrial fat, was accompanied by decreased
reservoir function though augmented LA kinetic energy
and ejection force. This supports the concept that such
regional adipose tissues can be beneficial by preserving
myocardial energy s upply under certain circumstances, yet
simultaneously impose certain negative effects generated
by inflammatory process. Similar paradoxical effects of
central 
obesity have been widely explored in previous
literature (33, 34, 35). Investigators had previously observed
an early reduction in LA reservoir and conduit functions
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along with compensatory increase in contractile function
among patients with either hypertension (36, 37) or heart
failure with preserved ejection fraction (32), possibly at the
expense of LA enlargement. Another reason for LA v
 olume
expansion was believed to result from compensatory
increased preload as a result of the optimal use of
Frank–Starling mechanism to provoke atrial muscle
shortening and contractility for same reasons (38). Taken
together, our findings can be interpreted as subclinical LA
functional disturbances possibly driven by the detrimental
effects of interatrial fat, leading to impaired LA reservoir and
conduit functions. On the meanwhile, cardiac performance
was preserved by LA enlargement and augmented LA
ejection force and kinetic energy in this process.

Potential clinical implications
A previous study showed that individuals without AF
history who had increased atrial fat infiltration may be
exposed to higher risk of developing AF, according to the
ARIC risk score. They also found that IAS width strongly
correlated with the extent of atrial fat infiltration (39). So
far, impaired LA reservoir and conduit functions in individuals with central obesity or metabolic derangements
had been speculated to be associated with AF substrate
formation (10, 11), which may be independent of LA size
(40). While different “weight” of various sites adiposity
on cardiac structure/functions or electrical properties
may exist (8, 9, 28), we and others demonstrated that
IAS fat infiltrate may be of potential clinical significance
(19, 38). In particular, as reported before, higher prevalence of atrial arrhythmias (for instance, AF) and overt
LA remodeling had been observed with lipomatous
septal hypertrophy (24). Compared with other fat depots,
interatrial fat burden was more strongly linked to deteriorated LA mechanics of several aspects in our work after
accounting for clinical covariates. An in-depth understanding of such findings may therefore help to identify
a specific population at higher risk of AF development in
daily practice. Thus, we speculate that early prevention
of such fat infiltration or aggressive control of underlying
clinical risks might prevent AF development, which may
require further confirmation in future research.
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retrospective and cross-sectional, without an elaborate
longitudinal follow-up of clinical outcomes. The actual
number of patients who developed AF or heart failure was
very low. This could be partially explained by the practice
of national health insurance, which mandates nearly full
population coverage in general disease management.
However, the lack of ambulatory ECG monitoring
rendered it impossible to determine whether silent
paroxysmal arrhythmias might be missed. Thirdly, we
primarily assessed LA volume by 2D echocardiography
at specific time points, which is limited in accuracy due
to the left atrium’s complex geometry and surrounding
structures. Data of advanced imaging techniques such as
speckle tracking and 3D-based echocardiography were also
limited. However, we also performed CT measurements on
nearly one-sixths of the study population, and the high
correlation suggested that the echocardiographic method
can be validated. Finally, although most data from our
analysis had high statistical significance, the actual
correlation was not strong, indicating that interatrial fat
is only a minority in the wide range of multiple factors
accounting for variations in LA mechanics.

Conclusions
This study showed that in an asymptomatic population,
regional adipose tissue may have a negative impact on
the LV geometry and LA remodeling process, which
primarily manifested as LA enlargement accompanied
by functional decline of several LA mechanics, including
conduit and reservoir functions. These remodeling
processes were associated with increased LA global kinetic
energy and 
ejection force at the hemodynamic level,
which may serve to compensate for those functional
deteriorations of LA in asymptomatic population. More
studies may be required to determine whether this
association with LA function was mainly a causative of
interatrial fat deposition, or vice versa.
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